Mathematical analysis reveals a degree-five modular structure for Ramanujan's level-11 dissections, highlighting connections between Kummer-line maps and cyclotomic phase ideals.
A previous Galois–Siegel framework for Ramanujan's prime dissections places the normalized p-th-power radicands arising from the Euler function, φ, and ψ on one cyclic modular-function cover with Galois group (Z/pZ)×/{±1}. A companion preprint made several cubic stages explicit. Here we cross to the first pure quintic case, p = 11, and obtain two complementary descriptions of the same degree-five structure. First, the five actual φ-dissection radicands are connected explicitly, through the binary distribution identity, to Y. Yang's low-height generalized-eta coordinate system on X₁(11). A primitive Hilbert–90 ratio is expressed as a monomial in five Yang conjugates evaluated at τ, 2τ, and 4τ; the relevant exponent orbit has Smith normal form diag(1,1,1,11,0). Second, the standard 5-isogeny X₁(11) → X₀(11) descends on the quotients by negation to a rational degree-five Kummer-line map whose fibre equation is the classical regular D₅ quintic. The modular curve X₀(11) realizes the quadratic subfield of this dihedral splitting field, so base change converts the D₅ cover into the cyclic C₅ modular isogeny. An exact differential identity is also obtained, and the specialization t = 7 yields an irreducible cyclic quintic of discriminant 11⁴, explicitly isomorphic to the maximal real subfield of Q(ζ₁₁). Finally, the 11-primary phase obstruction is reinterpreted cyclotomically. Under the natural identification of the augmentation lattice with Z[ζ₅], the balanced phase-annihilator lattice is the prime ideal (11, ζ₅ − 4), and Yang's exponent selector maps to a principal generator of norm 11. A corresponding phase-ideal statement is proved uniformly for safe primes p = 2ℓ + 1. The individual ingredients are classical; the Ramanujan-specific synthesis and its bibliographic priority have not yet undergone external specialist review.
No takes yet. Share an insight, caveat, or question.
David Gallouin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: